journal article·2022-04-08Open access

Fabrication and evaluation of a BMP-2/dexamethasone co-loaded gelatin sponge scaffold for rapid bone regeneration

Qi Gan, Hao Pan, Wenjing Zhang, Yuan Yuan, Jiangchao Qian, Changsheng Liu

Abstract

Abstract Improving the osteogenic activity of BMP-2 in vivo has significant clinical application value. In this research, we use a clinical gelatin sponge scaffold loaded with BMP-2 and dexamethasone (Dex) to evaluate the osteogenic activity of dual drugs via ectopic osteogenesis in vivo. We also investigate the mechanism of osteogenesis induced by BMP-2 and Dex with C2C12, a multipotent muscle-derived progenitor cell. The results show that the gelatin scaffold with Dex and BMP-2 can significantly accelerate osteogenesis in vivo. It is indicated that compared with the BMP-2 or Dex alone, 100 nM of Dex can dramatically enhance the BMP-2-induced alkaline phosphatase activity (ALP), ALP mRNA expression and mineralization. Further studies show that 100 nM of Dex can maintain the secondary structure of BMP-2 and facilitate recognition of BMP-2 with its receptors on the surface of C2C12 cells. We also find that in C2C12, Dex has no obvious effect on the BMP-2-induced Smad1/5/8 protein expression and the STAT3-dependent pathway, but Runx2-dependent pathway is involved in the Dex-stimulated osteoblast differentiation of BMP-2 both in vitro and in vivo. Based on these results, a potential mechanism model about the synergistic osteoinductive effect of Dex and BMP-2 in C2C12 cells via Runx2 activation is proposed. This may provide a theoretical basis for the pre-clinical application of Dex and BMP-2 for bone regeneration.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · TGF-β signaling in diseases · Mesenchymal stem cell research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory for Ultrafine Materials of Ministry of Education, East China University of Science and Technology, Shanghai 200237, PR China

The State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, PR China

Engineering Research Center for Biomedical Materials of the Ministry of Education, East China University of Science and Technology, Shanghai 200237, PR China

Frontiers Science Center for Materiobiology and Dynamic Chemistry, East China University of Science and Technology, Shanghai 200237, PR China

Funding

Natural Science Foundation of China for Innovative Research · National Natural Science Foundation of China

References (44)

Show source-provided references
1. Adult mesenchymal stem cells and impaction grafting: a new clinical paradigm shift10.1586/17434440.4.3.393 ↗
2. 3D bioprinting spatiotemporally defined patterns of growth factors to tightly control tissue regeneration10.1126/sciadv.abb5093 ↗
3. Combinatorial morphogenetic and mechanical cues to mimic bone development for defect repair10.1126/sciadv.aax2476 ↗
4. Recapitulating bone development through engineered mesenchymal condensations and mechanical cues for tissue regeneration10.1126/scitranslmed.aav7756 ↗
5. Bone morphogenetic proteins10.1080/08977190412331279890 ↗
6. Quantification of rhBMP2 in bioactive bone materials10.1093/rb/rbz038 ↗
7. Enhanced osteogenesis of hydroxyapatite scaffolds by coating with BMP-2-loaded short polylactide nanofiber: a new drug loading method for porous scaffolds
8. Signal transduction by the TGF-beta superfamily10.1126/science.1071809 ↗
9. A proton-responsive ensemble using mesocellular foam supports capped with N, O-carboxymethyl chitosan for controlled release of bioactive proteins10.1039/C5TB00219B ↗
10. Heparin-mediated delivery of bone morphogenetic protein-2 improves spatial localization of bone regeneration10.1126/sciadv.aay1240 ↗
11. A facile one-stage treatment of critical bone defects using a calcium sulfate/hydroxyapatite biomaterial providing spatiotemporal delivery of bone morphogenic protein-2 and zoledronic acid10.1126/sciadv.abc1779 ↗
12. Multifunctional scaffolds for facile implantation, spontaneous fixation, and accelerated long bone regeneration in rodents10.1126/scitranslmed.aau7411 ↗
13. Enhanced bone regeneration via spatiotemporal and controlled delivery of a genetically engineered BMP-2 in a composite Hydrogel10.1016/j.biomaterials.2021.121117 ↗
14. Local delivery of bone morphogenetic protein-2 from near infrared-responsive hydrogels for bone tissue regeneration10.1016/j.biomaterials.2020.119909 ↗
15. Fabrication and clinical application of easy-to-operate pre-cured CPC/rhBMP-2 micro-scaffolds for bone regeneration
16. Induction of bone formation by 3D biologically active scaffolds containing RGD-NPs, BMP2, and NtMPCs10.1002/adtp.202000245 ↗
17. Enhancement of BMP-2 and VEGF carried by mineralized collagen for mandibular bone regeneration10.1093/rb/rbaa022 ↗
18. Engineered bridge protein with dual affinity for bone morphogenetic protein-2 and collagen enhances bone regeneration for spinal fusion10.1126/sciadv.abh4302 ↗
19. Lysostaphin and BMP-2 co-delivery reduces S. aureus infection and regenerates critical-sized segmental bone defects10.1126/sciadv.aaw1228 ↗
20. A BMP/activin A chimera is superior to native BMPs and induces bone repair in nonhuman primates when delivered in a composite matrix10.1126/scitranslmed.aar4953 ↗
21. Sialic acid-modified dexamethasone lipid calcium phosphate gel core nanoparticles for target treatment of kidney injury10.1039/D0BM00581A ↗
22. Bone morphogenetic protein 2 and dexamethasone synergistically increase alkaline phosphatase levels through JAK/STAT signaling in C3H10T1/2 cells10.1002/jcp.22017 ↗
23. Dexamethasone modulates BMP-2 effects on mesenchymal stem cells in vitro10.1002/jor.20565 ↗
24. Injectable mechanical pillows for attenuation of load-induced post-traumatic osteoarthritis10.1093/rb/rbz013 ↗
25. Controlled dual delivery of BMP-2 and dexamethasone by nanoparticle-embedded electrospun nanofibers for the efficient repair of critical-sized rat calvarial defect10.1016/j.biomaterials.2014.10.015 ↗
26. Enhanced bioactivity of bone morphogenetic protein-2 with low dose of 2-N, 6-O-sulfated chitosan in vitro and in vivo10.1016/j.biomaterials.2008.12.016 ↗
27. Osteogenic differentiation of bone marrow stromal cells on poly(epsilon-caprolactone) nanofiber scaffolds10.1016/j.actbio.2010.02.006 ↗
28. Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts10.1016/j.steroids.2003.12.005 ↗
29. Inductive effects of dexamethasone on the mineralization and the osteoblastic gene expressions in mature osteoblast-like ROS17/2.8 cells10.1016/j.bbrc.2007.07.192 ↗
30. Osteogenic induction of hBMSCs by electrospun scaffolds with dexamethasone release functionality10.1016/j.biomaterials.2010.04.010 ↗
31. High concentrations of dexamethasone suppress the proliferation but not the differentiation or further maturation of human osteoblast precursors in vitro: relevance to glucocorticoid-induced osteoporosis10.1093/rheumatology/40.1.74 ↗
32. Osteoblastic differentiation of human and equine adult bone marrow-derived mesenchymal stem cells when BMP-2 or BMP-7 homodimer genetic modification is compared to BMP-2/7 heterodimer genetic modification in the presence and absence of dexamethasone10.1002/jor.21126 ↗
33. Estrogen and glucocorticoid regulate osteoblast differentiation through the interaction of bone morphogenetic protein-2 and tumor necrosis factor-alpha in C2C12 cells10.1016/j.mce.2010.05.004 ↗
34. A critical role for interleukin-6 family-mediated Stat3 activation in osteoblast differentiation and bone formation10.1016/j.bone.2006.02.074 ↗
35. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors10.1038/sj.onc.1203551 ↗
36. Molecular basis of the cell specificity of cytokine action
37. BMP2-activated Erk/MAP kinase stabilizes Runx2 by increasing p300 levels and histone acetyltransferase activity10.1074/jbc.M110.142307 ↗
38. Bone morphogenetic protein 2 activates Smad6 gene transcription through bone-specific transcription factor Runx210.1074/jbc.M610997200 ↗
39. Bone morphogenetic protein-2 stimulates Runx2 acetylation10.1074/jbc.M512494200 ↗
40. Glucocorticoid-induced osteogenesis is negatively regulated by Runx2/Cbfa1 serine phosphorylation10.1242/jcs.02758 ↗
41. Down-regulation of type I Runx2 mediated by dexamethasone is required for 3T3-L1 adipogenesis10.1210/me.2011-1287 ↗
42. The effect of timing in the administration of hepatocyte growth factor to modulate BMP-2-induced osteoblast differentiation10.1016/j.biomaterials.2009.10.048 ↗
43. Runx2 is a common target of transforming growth factor beta 1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C1210.1128/MCB.20.23.8783-8792.2000 ↗
44. Interaction and functional cooperation of PEBP2/CBF with Smads - Synergistic induction of the immunoglobulin germline C alpha promoter10.1074/jbc.274.44.31577 ↗